Note: Revenues for privately held companies are statistical evaluations.
Takeda Pharmaceuticals America's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry.
Note: Takeda Pharmaceuticals America's revenues are gauged from an analysis of company filings.
Takeda Pharmaceuticals America's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Takeda Pharmaceuticals America Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Takeda Pharmaceuticals America is developing and marketing.
Takeda Pharmaceuticals America doesn't have any recent trademark applications, indicating Takeda Pharmaceuticals America is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
DEXILANT SOLUTAB Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders
CONNECT2DAY Educational services, namely, conducting programs in the field of diabetes
DEXILANT MELT Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders
Determine whether Takeda Pharmaceuticals America grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Takeda Pharmaceuticals America is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Takeda Pharmaceuticals America's Largest Competitors
A competitive analysis shows these companies are in the same general field as Takeda Pharmaceuticals America, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Takeda Pharmaceuticals America.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Takeda Pharmaceuticals America and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.